Preventing dental caries through targeted treatment of acid-producing bacteria
通过针对性治疗产酸菌预防龋齿
基本信息
- 批准号:10474963
- 负责人:
- 金额:$ 72.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AcidsAdvanced DevelopmentAffectAnimal ModelAntimicrobial EffectBacteriaBiomassBuffersCarbohydratesCarbonCaries preventionChemical StructureChemistryChlorhexidineChronicClinicalCollaborationsCommunicable DiseasesConsequentialismDental ClinicsDental EnamelDental cariesDevelopmentDietary CarbohydratesEffectivenessEncapsulatedEquilibriumFeedbackFutureGoalsGrowthHumanIn VitroInfection preventionIntakeKineticsKnowledgeLengthMicrobial BiofilmsModelingMonitorMusNamesOralParticle SizePhysiologicalProductionPropertyResearchSalivaSaltsSeriesSilicon DioxideSodium ChlorideSolubilityStimulusStreptococcus mutansSucroseSurfaceTailTestingTooth structureTranslatingWateracronymsanalogantimicrobialantimicrobial drugaqueousbactericidebasebiomaterial compatibilitycariogenic bacteriacostdemineralizationdesigndysbiosiseffectiveness evaluationenvironmental changeimprovedin vivoinnovationlead candidatemicrobialmicrobial communitymicrobial compositionmicrobiomemultidisciplinarynanoparticlenoveloral microbial communitypolymicrobial biofilmpolymicrobial diseasepreventresearch clinical testingresponsetargeted treatmentwater solubility
项目摘要
Abstract: In today's microbiome era, it is well-recognized that dental caries, one of the most prevalent and costly
chronic infectious diseases world-wide, results from dysbiosis of the oral microbiota and the oral environmental
changes that cause tooth damage. Specifically, frequent intake of fermentable carbohydrates promotes a
progressive shift in microbial composition toward acidogenic and acid-tolerant species. The continual acid-
induced demineralization eventually overcomes the buffering capacity and anti-microbial properties of saliva,
leading to irreversible tooth destruction. The goal of this proposed research is to prevent dental caries through
targeted treatment of acid-producing bacteria (t-TAB). t-TAB will promote a healthy microbial community that is
vital for modulating pH and preventing acid-induced teeth damage. The t-TAB will be achieved by selectively
inhibiting the growth of cariogenic bacteria through enhanced antimicrobial (AM) efficacy in response to the
accelerated acid production by these bacteria in comparison to commensal species. We propose four specific
aims to develop, identify and assess effective t-TAB candidates. In Specific Aim 1, we will synthesize and
characterize six new pH-sensitive quaternary pyridinium salts (pH-QPSs). We expect to identify compounds or
combinations of compounds that provide t-TAB in aqueous mixtures. We will enhance our understanding of the
chemical structure/AM efficacy relationship and optimize the AM efficacy and solubility of pH-QPS(s) to obtain
safe and effective t-TAB treatments. In Specific Aim 2, we will transform a clinically tested AM agent,
chlorhexidine (CHX), into a t-TAB agent which provides pH-responsive AM efficacy. We will achieve acid
enhanced CHX release through encapsulated CHX in QPS-functionalized mesoporous silica nanoparticles. We
will also identify the synergistic pH-AM-E induced by interactions of CHX and pH-QPSs. In Specific Aim 3, we
will assess and compare the t-TAB efficacy of lead candidates from Aim 1 and Aim 2 by employing a multispecies
biofilm model that simulates human oral microbial community (named O-mix). The t-TAB efficacy will be
assessed in the presence and absence of sucrose—the cariogenic dietary carbohydrate. Strategy will entail
evaluating biomass, analyzing microbial profiles and determining environmental pH. Finally, the most effective
t-TAB candidates that successfully inhibit the growth of cariogenic acid-producing bacteria without affecting the
functions of commensal species will be further assessed in Specific Aim 4 in vitro using a microbial-caries model
on human enamel and in vivo employing a well-developed mouse caries model. Successful completion of the
proposed aims will provide new materials for oral rinse in dental clinics to prevent/treat dental caries. Knowledge
gained from this study will also advance material development to prevent infection and erosion.
翻译后摘要:在今天的微生物组时代,这是公认的,龋齿,最普遍和昂贵的
慢性感染性疾病是由口腔微生物群和口腔环境的生态失调引起的
导致牙齿损伤的变化。具体来说,频繁摄入可发酵碳水化合物会促进
微生物组成逐渐向产酸和耐酸物种转变。不断的酸-
诱导的脱矿作用最终克服了唾液的缓冲能力和抗微生物特性,
导致不可逆的牙齿破坏。这项拟议研究的目标是通过以下方法预防龋齿:
产酸细菌的靶向治疗(t-TAB)。t-TAB将促进健康的微生物群落,
对调节pH值和防止酸引起的牙齿损伤至关重要。t-TAB将通过选择性地
通过增强的抗微生物(AM)功效来抑制致龋细菌的生长,
加速了这些细菌的产酸。我们提出四个具体的
旨在开发,识别和评估有效的t-TAB候选人。在具体目标1中,我们将综合和
表征了六种新的pH敏感性季铵吡啶盐(pH-QPSs)。我们希望能鉴定出化合物,
在水性混合物中提供t-TAB的化合物的组合。我们会加强对
化学结构/AM功效关系,并优化pH-QPS(s)的AM功效和溶解度,以获得
安全有效的t-TAB治疗。在《特定目标2》中,我们将改造一个经过临床测试的AM代理,
氯己定(CHX)转化为提供pH响应性AM功效的t-TAB试剂。我们将实现酸
通过将CHX包封在QPS官能化的介孔二氧化硅纳米颗粒中来增强CHX释放。我们
还将鉴定由CHX和pH-QPS的相互作用诱导的协同pH-AM-E。在具体目标3中,我们
将通过采用多物种评估和比较目标1和目标2的主要候选物的t-TAB功效,
模拟人类口腔微生物群落的生物膜模型(命名为O-mix)。t-TAB疗效将是
在存在和不存在蔗糖-致龋膳食碳水化合物的情况下进行评估。战略将包括
评估生物量,分析微生物概况和确定环境pH值。最后,
成功抑制产龋细菌生长而不影响细菌生长的t-TAB候选物,
在《特定目标4》中,将使用微生物-龋齿模型在体外进一步评估牙菌斑物种的功能
在人牙釉质和体内采用发育良好的小鼠龋齿模型。成功完成
拟议的目标是为牙科诊所提供新的口腔冲洗材料,以预防/治疗龋齿。知识
从这项研究中获得的信息也将促进材料的发展,以防止感染和侵蚀。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xuesong He其他文献
Xuesong He的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xuesong He', 18)}}的其他基金
Diversity supplement for R01DE029479-01A1 to support Dr. Jeremy Elias
R01DE029479-01A1 的多样性补充品以支持 Jeremy Elias 博士
- 批准号:
10648830 - 财政年份:2022
- 资助金额:
$ 72.09万 - 项目类别:
Host tRNA-derived small RNAs (tsRNAs) mediate interactions between host and oral microbes
宿主 tRNA 衍生的小 RNA (tsRNA) 介导宿主和口腔微生物之间的相互作用
- 批准号:
10446416 - 财政年份:2022
- 资助金额:
$ 72.09万 - 项目类别:
Host tRNA-derived small RNAs (tsRNAs) mediate interactions between host and oral microbes
宿主 tRNA 衍生的小 RNA (tsRNA) 介导宿主和口腔微生物之间的相互作用
- 批准号:
10577837 - 财政年份:2022
- 资助金额:
$ 72.09万 - 项目类别:
pH-sensitive materials responding to metabolic activities of cariogenic plaque
响应致龋菌斑代谢活动的 pH 敏感材料
- 批准号:
10457152 - 财政年份:2021
- 资助金额:
$ 72.09万 - 项目类别:
Preventing dental caries through targeted treatment of acid-producing bacteria
通过针对性治疗产酸菌预防龋齿
- 批准号:
10896092 - 财政年份:2021
- 资助金额:
$ 72.09万 - 项目类别:
pH-sensitive materials responding to metabolic activities of cariogenic plaque
响应致龋菌斑代谢活动的 pH 敏感材料
- 批准号:
10043261 - 财政年份:2020
- 资助金额:
$ 72.09万 - 项目类别:
Studying the Protective Effects of Normal Oral Flora
研究正常口腔菌群的保护作用
- 批准号:
9982063 - 财政年份:2018
- 资助金额:
$ 72.09万 - 项目类别:
Studying the Protective Effects of Normal Oral Flora
研究正常口腔菌群的保护作用
- 批准号:
9323373 - 财政年份:2016
- 资助金额:
$ 72.09万 - 项目类别:
Domestication and characterization of TM7-the most elusive oral phylum
TM7——最难以捉摸的口腔门的驯化和表征
- 批准号:
8612839 - 财政年份:2014
- 资助金额:
$ 72.09万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 72.09万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 72.09万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 72.09万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 72.09万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 72.09万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 72.09万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 72.09万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 72.09万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 72.09万 - 项目类别: